1-3 of 3
Sushanth Gouni
Close
Sort by
Journal Articles

A Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell Therapy

Sushanth Gouni, Allison C. Rosenthal, Jennifer L. Crombie, Andrew Ip, Manali Kamdar, Brian T. Hess, Lei Feng, Grace Watson, Amy Ayers, Sattva S. Neelapu, Arushi Khurana, Madiha Iqbal, Yi Lin, Reid W Merryman, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 2495.
https://doi.org/10.1182/blood-2021-147591
Published: 2021
Journal Articles

Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion

Sushanth Gouni, Jason R. Westin, Haleigh Mistry, Raphael Eric Steiner, Jinsu James, Simrit Parmar, Mansoor Noorani, Nathan H. Fowler, Sandra B. Horowitz, Lei Feng, Luis E. Fayad, Swaminathan P Iyer, Michael R Green, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta Nastoupil, Sattva S. Neelapu, Yago Nieto, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2021-145503
Published: 2021
Journal Articles

Use of Medium Potency Statins Is Associated with Improved Outcomes after Frontline RCHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Sushanth Gouni, MD, Paolo Strati, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Raphael E Steiner, MD, Ranjit Nair, MD, Luis Fayad, Sattva S. Neelapu, MD, Ralf Landgraf, PhD, Daniel Bilbao, PhD, Francisco Vega, MDPhD, Nitin Agarwal, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45.
https://doi.org/10.1182/blood-2020-136010
Published: 2020